TY  - GEN
AU  - Becker,Richard C
AU  - Alexander,John H
AU  - Newby,L Kristin
AU  - Yang,Hongqiu
AU  - Barrett,Yuchen
AU  - Mohan,Puneet
AU  - Wang,Jessie
AU  - Harrington,Robert A
AU  - Wallentin,Lars C
TI  - Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome
SN  - 2567-689X
PY  - 2011///0408
KW  - Acute Coronary Syndrome
KW  - blood
KW  - Administration, Oral
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Biomarkers
KW  - Blood Coagulation
KW  - drug effects
KW  - Chi-Square Distribution
KW  - Chromatography, Liquid
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Down-Regulation
KW  - Enzyme-Linked Immunosorbent Assay
KW  - Factor Xa
KW  - metabolism
KW  - Factor Xa Inhibitors
KW  - Female
KW  - Fibrin Fibrinogen Degradation Products
KW  - Fibrinolytic Agents
KW  - administration & dosage
KW  - Humans
KW  - International Normalized Ratio
KW  - Male
KW  - Middle Aged
KW  - Odds Ratio
KW  - Partial Thromboplastin Time
KW  - Peptide Fragments
KW  - Placebo Effect
KW  - Prothrombin
KW  - Pyrazoles
KW  - Pyridones
KW  - Tandem Mass Spectrometry
KW  - Thrombin
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1160/TH10-04-0247
ER  -